[Effect of tactivin in vitro on lymphocytes from patients with acute hepatitis B].
In vitro experiments have revealed that Tactivin increases the number of lymphocytes and their functional activity in patients with acute virus hepatitis B. Under the action of Tactivin the increase of theophylline-resistant and theophylline-sensitive T-lymphocytes occurs in patients with acute virus hepatitis B in a moderate or severe form. In a mild form of acute virus hepatitis B and in healthy persons Tactivin produces no in vitro changes in T-lymphocyte subpopulations.
Ryndina
E I
EI
North Ossetian Medical Academy, Vladikavkaz, Russia.
D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D016207:Cytokines / Q000378:metabolism; D003602:Cytotoxicity, Immunologic; D006509:Hepatitis B / Q000097:blood*; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D010455:Peptides / Q000494:pharmacology*; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D013949:Thymus Extracts / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; D016207:Cytokines; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin